Immunocore Holdings plcIMCR stock score: 51/100

$26.63 · -3.20% · Scored Nov 19, 2026

Technical
26
Fundamental
57
News
53

The reading

Immunocore Holdings (IMCR) scores 51 out of 100, which reads neutral, higher than 51% of Healthcare stocks and 47% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 57, technicals 26.

Among the fundamentals, Price Target at 100 and Revenue Quality (Quarterly) at 100 score highest, while Earnings Growth (5-Year) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 17 and contrarian oscillators 69 — a split worth reading before trusting the technical total.

News sentiment is neutral at 53; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 37 to 53, and it ends the period where it started.

About Immunocore Holdings

Immunocore (IMCR) is a commercial-stage biotechnology company based in the United Kingdom that develops medicines from its ImmTAX platform, which uses engineered T cell receptors to direct the immune system against specific targets. Its marketed drug, KIMMTRAK, is approved in the United States, Europe and other countries for adults with a form of metastatic uveal melanoma, a rare eye cancer, and it was the first approved therapy of its kind. The company sells KIMMTRAK directly in major markets and through distributors elsewhere, and product sales provide most of its revenue. Its lead pipeline candidate, brenetafusp, targets a protein called PRAME that appears in many cancers and is in late-stage testing in advanced cutaneous melanoma, with studies in other tumors as well. Immunocore also works on candidates for infectious and autoimmune diseases.

Immunocore competes with large cancer drug makers such as Merck, Bristol Myers Squibb and Roche, which sell immunotherapies used in melanoma, and with companies developing T cell receptor and bispecific therapies such as Immatics. Its edge rests on a first-in-class approved product that funds research and on a platform that can reach targets inside cells that antibodies cannot. Investors who follow IMCR stock tend to watch KIMMTRAK sales and patient uptake. Results from the late-stage brenetafusp melanoma trial are closely followed. Pipeline progress, operating expenses and the cash balance are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward IMCR’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

57

Pulling it up

  • Price target score compares the current stock price to analyst consensus targets.

  • How the latest quarter's revenue compares with the average of the last four, plus a bonus for steady quarterly revenue.

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

Holding it back

  • 5-year earnings growth evaluates long-term profit trajectory and consistency.

  • Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

  • Gross margins show profitability after cost of goods sold.

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

23

Pulling it up

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Williams %R (28-period) places the close within the last 28 periods' high-low range.

Holding it back

  • Where the price sits between its 52-week low and high.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Simple Moving Average (10-period) smooths price action over 10 periods.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
53

Technical score by timeframe

ChartScoreWeight
Hourly371
Daily233
Weekly222
Monthly302

Composite score, last 90 days

05010051Aug 23, 2026Nov 19, 2026Aug 23, 2026: 51Aug 24, 2026: 51Aug 25, 2026: 52Aug 26, 2026: 51Aug 27, 2026: 50Aug 28, 2026: 50Aug 29, 2026: 50Aug 30, 2026: 50Aug 31, 2026: 50Sep 1, 2026: 52Sep 2, 2026: 52Sep 3, 2026: 52Sep 4, 2026: 49Sep 5, 2026: 50Sep 6, 2026: 50Sep 7, 2026: 50Sep 8, 2026: 48Sep 9, 2026: 46Sep 10, 2026: 45Sep 11, 2026: 43Sep 12, 2026: 43Sep 13, 2026: 43Sep 14, 2026: 43Sep 15, 2026: 41Sep 16, 2026: 40Sep 17, 2026: 44Sep 18, 2026: 42Sep 19, 2026: 42Sep 20, 2026: 42Sep 21, 2026: 43Sep 22, 2026: 42Sep 23, 2026: 42Sep 24, 2026: 42Sep 25, 2026: 39Sep 26, 2026: 39Sep 27, 2026: 39Sep 28, 2026: 39Sep 29, 2026: 39Sep 30, 2026: 38Oct 1, 2026: 39Oct 2, 2026: 38Oct 3, 2026: 38Oct 4, 2026: 38Oct 5, 2026: 38Oct 6, 2026: 38Oct 7, 2026: 38Oct 8, 2026: 38Oct 9, 2026: 39Oct 10, 2026: 39Oct 11, 2026: 39Oct 12, 2026: 38Oct 13, 2026: 37Oct 14, 2026: 37Oct 15, 2026: 39Oct 16, 2026: 39Oct 17, 2026: 39Oct 18, 2026: 39Oct 19, 2026: 40Oct 20, 2026: 45Oct 21, 2026: 45Oct 22, 2026: 45Oct 23, 2026: 41Oct 24, 2026: 41Oct 25, 2026: 41Oct 26, 2026: 42Oct 27, 2026: 44Oct 28, 2026: 45Oct 29, 2026: 43Oct 30, 2026: 40Nov 1, 2026: 41Nov 2, 2026: 40Nov 3, 2026: 40Nov 4, 2026: 38Nov 5, 2026: 37Nov 6, 2026: 41Nov 7, 2026: 41Nov 8, 2026: 41Nov 10, 2026: 46Nov 11, 2026: 45Nov 12, 2026: 53Nov 13, 2026: 52Nov 14, 2026: 52Nov 15, 2026: 52Nov 16, 2026: 52Nov 17, 2026: 51Nov 18, 2026: 51Nov 19, 2026: 51
Show the daily numbers
DateComposite
Nov 19, 202651
Nov 18, 202651
Nov 17, 202651
Nov 16, 202652
Nov 15, 202652
Nov 14, 202652
Nov 13, 202652
Nov 12, 202653
Nov 11, 202645
Nov 10, 202646
Nov 8, 202641
Nov 7, 202641
Nov 6, 202641
Nov 5, 202637
Nov 4, 202638
Nov 3, 202640
Nov 2, 202640
Nov 1, 202641
Oct 30, 202640
Oct 29, 202643
Oct 28, 202645
Oct 27, 202644
Oct 26, 202642
Oct 25, 202641
Oct 24, 202641
Oct 23, 202641
Oct 22, 202645
Oct 21, 202645
Oct 20, 202645
Oct 19, 202640
Oct 18, 202639
Oct 17, 202639
Oct 16, 202639
Oct 15, 202639
Oct 14, 202637
Oct 13, 202637
Oct 12, 202638
Oct 11, 202639
Oct 10, 202639
Oct 9, 202639
Oct 8, 202638
Oct 7, 202638
Oct 6, 202638
Oct 5, 202638
Oct 4, 202638
Oct 3, 202638
Oct 2, 202638
Oct 1, 202639
Sep 30, 202638
Sep 29, 202639
Sep 28, 202639
Sep 27, 202639
Sep 26, 202639
Sep 25, 202639
Sep 24, 202642
Sep 23, 202642
Sep 22, 202642
Sep 21, 202643
Sep 20, 202642
Sep 19, 202642
Sep 18, 202642
Sep 17, 202644
Sep 16, 202640
Sep 15, 202641
Sep 14, 202643
Sep 13, 202643
Sep 12, 202643
Sep 11, 202643
Sep 10, 202645
Sep 9, 202646
Sep 8, 202648
Sep 7, 202650
Sep 6, 202650
Sep 5, 202650
Sep 4, 202649
Sep 3, 202652
Sep 2, 202652
Sep 1, 202652
Aug 31, 202650
Aug 30, 202650
Aug 29, 202650
Aug 28, 202650
Aug 27, 202650
Aug 26, 202651
Aug 25, 202652
Aug 24, 202651
Aug 23, 202651

Key facts

Market cap
$1.4B
Sector
Healthcare
Industry
Biotechnology
Beta
0.81
Risk grade (1–10)
—
Next earnings
Nov 6, 2026

Questions

What is IMCR's stock rating today?

IMCR scores 51/100 (Neutral) as of Nov 19, 2026: technical 26, fundamental 57, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.

What does Immunocore Holdings do?

Immunocore (IMCR) is a commercial-stage biotechnology company based in the United Kingdom that develops medicines from its ImmTAX platform, which uses engineered T cell receptors to direct the immune system against specific targets. Its marketed drug, KIMMTRAK, is approved in the United States, Europe and other countries for adults with a form of metastatic uveal melanoma, a rare eye cancer, and it was the first approved therapy of its kind.

Is IMCR stock a buy?

The score is not a buy or sell recommendation. A 51 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the IMCR score calculated?

99 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

IMCR stock score

HTML

<a href="https://stocksscores.com/stocks/imcr/"><img src="https://stocksscores.com/stocks/imcr/badge.svg" alt="IMCR stock score" height="20"></a>

Markdown

[![IMCR stock score](https://stocksscores.com/stocks/imcr/badge.svg)](https://stocksscores.com/stocks/imcr/)